Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

This study is testing a second-generation version of a small eye implant that slowly releases a glaucoma medication (travoprost) to lower eye pressure over time, offering a potential alternative to daily eye drops. **You may be eligible if...** - You have been diagnosed with open-angle glaucoma or ocular hypertension (high eye pressure) in the study eye **You may NOT be eligible if...** - You have previously had incisional (cutting) glaucoma surgery in the study eye - You have had argon laser trabeculoplasty (ALT) — a specific laser procedure — in the study eye - You have had minimally invasive glaucoma surgery (MIGS) in the study eye Talk to your doctor to see if this trial is right for you.